Fifty-two patients with advanced upper abdominal malignancies and incapacitating pain were equally randomized to receive a combined neurolytic block of the celiac and superior hypogastric plexuses ( combined group ) or a neurolytic celiac plexus block alone ( NCPB group ) using a 90 % ethanol trans-intervertebral disk approach under CT guidance .